This document compares key aspects of different hepatitis viruses:
1. Hepatitis A, B, C, D, and E viruses differ in their genetics, whether they have an envelope, and their incubation periods.
2. Vaccines exist for hepatitis A and B but not C, D, or E. Diagnosis of the different hepatitis viruses can be made through various antibody and antigen tests.
3. Treatment involves vaccination and supportive therapy. Therapies with interferons and other drugs exist for hepatitis B and C but only supportive care for D and E.
This document compares key aspects of different hepatitis viruses:
1. Hepatitis A, B, C, D, and E viruses differ in their genetics, whether they have an envelope, and their incubation periods.
2. Vaccines exist for hepatitis A and B but not C, D, or E. Diagnosis of the different hepatitis viruses can be made through various antibody and antigen tests.
3. Treatment involves vaccination and supportive therapy. Therapies with interferons and other drugs exist for hepatitis B and C but only supportive care for D and E.
This document compares key aspects of different hepatitis viruses:
1. Hepatitis A, B, C, D, and E viruses differ in their genetics, whether they have an envelope, and their incubation periods.
2. Vaccines exist for hepatitis A and B but not C, D, or E. Diagnosis of the different hepatitis viruses can be made through various antibody and antigen tests.
3. Treatment involves vaccination and supportive therapy. Therapies with interferons and other drugs exist for hepatitis B and C but only supportive care for D and E.
This document compares key aspects of different hepatitis viruses:
1. Hepatitis A, B, C, D, and E viruses differ in their genetics, whether they have an envelope, and their incubation periods.
2. Vaccines exist for hepatitis A and B but not C, D, or E. Diagnosis of the different hepatitis viruses can be made through various antibody and antigen tests.
3. Treatment involves vaccination and supportive therapy. Therapies with interferons and other drugs exist for hepatitis B and C but only supportive care for D and E.
Download as DOCX, PDF, TXT or read online from Scribd
Download as docx, pdf, or txt
You are on page 1of 1
Type HAV HBV HCV HDV HEV
Genetics ssRNA dsDNA ssRNA Small
circular ssRNA Envelope Non-env. env. Env. Env. Incub. Period 2-6 wks 2-6 Months 3 months mean 6-8 weeks It occurs in the presence of HBV only
30-40 days/self limiting Vaccine inactiv. HAV anti- HBsAG/recombinant DNA technology No vaccine/continuously changing No vaccine No vaccine Diagnosis anti-Hav Igm First HBsAg then HBeAg appears next. *Anti-HCV IgM indicates infection. *HCV-specific IgM indicates exposure Diag. presence of IgM for HDV. Specific IgM and IgG Treatment H HB BI IG G & & S Su up pp po or rt t. . T Th he er ra ap py y alpha-interferon & ribavirin, for 6-12 months Interferon- alpha+ Lamivudine Only supportive therapy